These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 25951294)

  • 1. N-(1'-naphthyl)-3,4,5-trimethoxybenzohydrazide as microtubule destabilizer: Synthesis, cytotoxicity, inhibition of cell migration and in vivo activity against acute lymphoblastic leukemia.
    Salum LB; Mascarello A; Canevarolo RR; Altei WF; Laranjeira AB; Neuenfeldt PD; Stumpf TR; Chiaradia-Delatorre LD; Vollmer LL; Daghestani HN; de Souza Melo CP; Silveira AB; Leal PC; Frederico MJ; do Nascimento LF; Santos AR; Andricopulo AD; Day BW; Yunes RA; Vogt A; Yunes JA; Nunes RJ
    Eur J Med Chem; 2015; 96():504-18. PubMed ID: 25951294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents.
    Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L
    Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Novel Bis(indolyl)-hydrazide-Hydrazone Derivatives as Potent Microtubule-Targeting Cytotoxic Agents against A549 Lung Cancer Cells.
    Das Mukherjee D; Kumar NM; Tantak MP; Das A; Ganguli A; Datta S; Kumar D; Chakrabarti G
    Biochemistry; 2016 May; 55(21):3020-35. PubMed ID: 27110637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
    Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
    Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of New Antiproliferative Imidazopyrazole Acylhydrazones Able To Interact with Microtubule Systems.
    Brullo C; Rapetti F; Alfei S; Maric I; Rizzelli F; Mapelli M; Rosano C; Viale M; Bruno O
    ChemMedChem; 2020 Jun; 15(11):961-969. PubMed ID: 32233110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of a Series of Acridinones as Mechanism-Based Tubulin Assembly Inhibitors with Anticancer Activity.
    Magalhaes LG; Marques FB; da Fonseca MB; Rogério KR; Graebin CS; Andricopulo AD
    PLoS One; 2016; 11(8):e0160842. PubMed ID: 27508497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of bis(indolyl)ketohydrazide-hydrazones: Identification of potent and selective novel tubulin inhibitors.
    Tantak MP; Klingler L; Arun V; Kumar A; Sadana R; Kumar D
    Eur J Med Chem; 2017 Aug; 136():184-194. PubMed ID: 28494255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel vinyl sulfone derivatives as anti-tumor agents with microtubule polymerization inhibitory and vascular disrupting activities.
    Li W; Yin Y; Yao H; Shuai W; Sun H; Xu S; Liu J; Yao H; Zhu Z; Xu J
    Eur J Med Chem; 2018 Sep; 157():1068-1080. PubMed ID: 30176537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and SAR requirements of adamantane-colchicine conjugates with both microtubule depolymerizing and tubulin clustering activities.
    Zefirova ON; Nurieva EV; Shishov DV; Baskin II; Fuchs F; Lemcke H; Schröder F; Weiss DG; Zefirov NS; Kuznetsov SA
    Bioorg Med Chem; 2011 Sep; 19(18):5529-38. PubMed ID: 21873068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel derivatives of 1,3,4-oxadiazoles are potent mitostatic agents featuring strong microtubule depolymerizing activity in the sea urchin embryo and cell culture assays.
    Kiselyov AS; Semenova MN; Chernyshova NB; Leitao A; Samet AV; Kislyi KA; Raihstat MM; Oprea T; Lemcke H; Lantow M; Weiss DG; Ikizalp NN; Kuznetsov SA; Semenov VV
    Eur J Med Chem; 2010 May; 45(5):1683-97. PubMed ID: 20110137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
    Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
    Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents.
    Xu F; Li W; Shuai W; Yang L; Bi Y; Ma C; Yao H; Xu S; Zhu Z; Xu J
    Eur J Med Chem; 2019 Jul; 173():1-14. PubMed ID: 30981112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells.
    Yan J; Pang Y; Sheng J; Wang Y; Chen J; Hu J; Huang L; Li X
    Biochem Pharmacol; 2015 Sep; 97(1):51-61. PubMed ID: 26212540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
    Dandawate P; Ahmad A; Deshpande J; Swamy KV; Khan EM; Khetmalas M; Padhye S; Sarkar F
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2900-4. PubMed ID: 24835626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1H-benzimidazole-2-yl hydrazones as tubulin-targeting agents: Synthesis, structural characterization, anthelmintic activity and antiproliferative activity against MCF-7 breast carcinoma cells and molecular docking studies.
    Anichina K; Argirova M; Tzoneva R; Uzunova V; Mavrova A; Vuchev D; Popova-Daskalova G; Fratev F; Guncheva M; Yancheva D
    Chem Biol Interact; 2021 Aug; 345():109540. PubMed ID: 34139148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of novel 5,6,7-trimethoxy-N-aryl-2-styrylquinolin-4-amines as potential anticancer agents and tubulin polymerization inhibitors.
    Mirzaei S; Eisvand F; Hadizadeh F; Mosaffa F; Ghasemi A; Ghodsi R
    Bioorg Chem; 2020 May; 98():103711. PubMed ID: 32179282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
    Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY
    J Pharmacol Exp Ther; 2007 Oct; 323(1):398-405. PubMed ID: 17660383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of 1-substituted -2-aryl imidazoles targeting tubulin polymerization as potential anticancer agents.
    Li L; Quan D; Chen J; Ding J; Zhao J; Lv L; Chen J
    Eur J Med Chem; 2019 Dec; 184():111732. PubMed ID: 31610372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of 2-alkoxy and 2-benzyloxy analogues of estradiol as anti-breast cancer agents through microtubule stabilization.
    Sathish Kumar B; Kumar A; Singh J; Hasanain M; Singh A; Fatima K; Yadav DK; Shukla V; Luqman S; Khan F; Chanda D; Sarkar J; Konwar R; Dwivedi A; Negi AS
    Eur J Med Chem; 2014 Oct; 86():740-51. PubMed ID: 25238172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents.
    Kim ND; Park ES; Kim YH; Moon SK; Lee SS; Ahn SK; Yu DY; No KT; Kim KH
    Bioorg Med Chem; 2010 Oct; 18(19):7092-100. PubMed ID: 20810285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.